Successful treatment of adult onset Langerhans cell histiocytosis with multi-drug combination therapy

Internal Medicine

Volumn 50, Issue 8, 2011, Pages 909-914

  Matsuki, Eri ^a   Tsukada, Yuiko ^a   Nakaya, Aya ^b   Yokoyama, Kenji ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Adults; Combination chemotherapy; Langerhans cell histiocytosis

Indexed keywords

C REACTIVE PROTEIN; MERCAPTOPURINE; PREDNISONE; VINBLASTINE;

ADULT; ARTICLE; BONE LESION; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES INSIPIDUS; DISEASE CONTROL; DRUG DOSE REDUCTION; EOSINOPHIL COUNT; FEMALE; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; LUNG NODULE; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; RASH; SERUM OSMOLALITY; SKIN BIOPSY; THORAX RADIOGRAPHY; URINE OSMOLALITY;

6-MERCAPTOPURINE; ADULT; AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PREDNISONE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VINBLASTINE;

EID: 79955551409     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4808     Document Type: Article

References (16)

1. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis. Cancer 85: 2278-2290, 1999.
2. Willis B, Ablin A, Weinberg V, Zoger S, William MW, Matthay KK. Disease course and late sequalae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. J Clin Oncol 14: 2073-2082, 1996.
3. Satter EK, High WA. Langerhans cell histiocytosis: a review of the current recommendations of the Histiocyte Society. Pediatr Dermatol 25: 291-295, 2008.
4. Alston RD, Tatevossian RG, McNally RJQ, Kelsey A, Birch JM, Eden TOB. Incidence and survival of childhood Langerhans cell histiocytosis in northwest England from 1954 to 1998. Pediatr Blood Cancer 48: 555-560, 2007.
5. Arico M, Girshikofsky M, Genereau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39: 2341-2348, 2003.
6. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. European J Haematol 76: 363-368, 2006.
7. Scolozzi P, Lombardi T, Monnier P, Jaques B. Multisystem Langerhans' cell histiocytosis (Hand-Schüller-Christian disease) in an adult: a case report and review of the literature. Eur Arch Otorhinolaryngol 261: 326-330, 2004.
8. Giona F, Caruso R, Testi AM, et al. Langerhans' cell histiocytosis in adults. Cancer 80: 1786-1791, 1997.
9. von Stebut E, Schadmand-Fischer S, Brauninger W, Kreft A, Doberauer C, Steinbrink K. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine. Archiv Dermatol 144: 649-653, 2008.
10. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin N Am 12: 327-337, 1998.
11. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 39: 571-585, 2002.
12. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. JrPediatr 138: 728-734, 2001.
13. Gadner H, Grois N, Potschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111: 2556-2562, 2008.
14. Tsele E, Thomas D, Chu A. Treatment of adult Langerhans cell histiocytosis with etoposide. J Am Acad Dermatol 7: 61-64, 1992.
15. Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood 93: 4125-4130, 1999.
16. Derenzini E, Fina MP, Stefoni V, et al. MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Annals Oncol 21: 1173-1178, 2010.